Huntington's treatment quest reaches first pluripotent stem cell trial, with safety now under review
An update on the first clinical trial evaluating a pluripotent stem cell-derived neural stem cell therapy for Huntington's disease was presented at the ISSCR 2026 Annual Meeting. The Phase Ib/IIa REGEN4HD study represents ...
Jul 9, 2026
0
3









